AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

THE WOODLANDS, Texas, and CAMBRIDGE, Mass., Oct. 29, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it ...

Passage Bio, Inc. ((PASG)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

Artiva Biotherapeutics, Inc. ((ARTV)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...

Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China Department of Thoracic Surgery, Anhui Chest Hospital, Hefei 230022, Anhui, China ...

"This partnership marks a pivotal moment not just for our company, but for the region's clean-energy future," said Sumit Majumdar, President & CEO of Buffalo Biodiesel. "With Verite's backing, we can ...

SAN CARLOS, Calif. and DALLAS, Oct. 23, 2025 /PRNewswire/ -- CAGE Bio Inc., a clinical-stage biotechnology company pioneering novel immunomodulatory therapies for dermatological diseases, today ...

Regeneron has given up on a CAR-T candidate acquired from 2seventy bio last year, before it entered the second part of a phase 1/2 lymphoma study. The dual-targeting CAR-T, dubbed bbT369, was being ...

Warframe is a bit of an enigma. To spectators it's a fast-paced, uber-complicated hack and slash fest, with billions of resources, a dictionary's worth of bizarre words, and an aesthetic that fuses ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Penn spinoff aiming to ...

GENEVA--(BUSINESS WIRE)--Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a ...

New data from pivotal Phase 3 ROSELLA trial reinforce relacorilant plus nab-paclitaxel improves progression-free and overall survival in patients with platinum-resistant ovarian cancer, with no need ...